ARTICLE | Company News
Eukarion Inc. other research news
November 5, 2001 8:00 AM UTC
Researchers published in the Journal of Neuroscience that treatment of superoxide dismutase-2 (SOD-2) knockout mice with SCSs increased survival by 3-fold compared to untreated mice (p<0.05). They als...